Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle
Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle Henning F. Kramer 1 , Carol A. Witczak 1 , Nobuharu Fujii 1 , Niels Jessen 1 , Eric B. Taylor 1 , David E. Arnolds 1 , Kei Sakamoto 1 , Michael F. Hirshman 1 and Laurie J. Goodyear...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2006-07, Vol.55 (7), p.2067-2076 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle
Henning F. Kramer 1 ,
Carol A. Witczak 1 ,
Nobuharu Fujii 1 ,
Niels Jessen 1 ,
Eric B. Taylor 1 ,
David E. Arnolds 1 ,
Kei Sakamoto 1 ,
Michael F. Hirshman 1 and
Laurie J. Goodyear 1 2
1 Metabolism Research Division, Joslin Diabetes Center, Boston, Massachusetts
2 Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Address correspondence and reprint requests to Laurie J. Goodyear, Section Head, Metabolism, Joslin Diabetes Center, One Joslin
Pl., Boston, MA 02215. E-mail: laurie.goodyear{at}joslin.harvard.edu
Abstract
Insulin and contraction increase GLUT4 translocation in skeletal muscle via distinct signaling mechanisms. Akt substrate of
160 kDa (AS160) mediates insulin-stimulated GLUT4 translocation in L6 myotubes, presumably through activation of Akt. Using
in vivo, in vitro, and in situ methods, insulin, contraction, and the AMP-activated protein kinase (AMPK) activator AICAR
all increased AS160 phosphorylation in mouse skeletal muscle. Insulin-stimulated AS160 phosphorylation was fully blunted by
wortmannin in vitro and in Akt2 knockout (KO) mice in vivo. In contrast, contraction-stimulated AS160 phosphorylation was
only partially decreased by wortmannin and unaffected in Akt2 KO mice, suggesting additional regulatory mechanisms. To determine
if AMPK mediates AS160 signaling, we used AMPK α2-inactive (α2i) transgenic mice. AICAR-stimulated AS160 phosphorylation was
fully inhibited, whereas contraction-stimulated AS160 phosphorylation was partially reduced in the AMPK α2i transgenic mice.
Combined AMPK α2 and Akt inhibition by wortmannin treatment of AMPK α2 transgenic mice did not fully ablate contraction-stimulated
AS160 phosphorylation. Maximal insulin, together with either AICAR or contraction, increased AS160 phosphorylation in an additive
manner. In conclusion, AS160 may be a point of convergence linking insulin, contraction, and AICAR signaling. While Akt and
AMPK α2 activities are essential for AS160 phosphorylation by insulin and AICAR, respectively, neither kinase is indispensable
for the entire effects of contraction on AS160 phosphorylation.
α2i, α2-inactive
AMPK, AMP-activated protein kinase
aPKC, atypical protein kinase C
AS160, Akt substrate of 160 kDa
EDL, extensor digitorum longus
GAP, GTPase-activating protein
PAS, phospho-Akt substrate
PI3-K, phosphatidylinositol 3-kinase
Footnotes
The cos |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/db06-0150 |